Advertisement, born in 1920, was diagnosed with cervical cancer by doctors at Johns Hopkins Hospital in early 1951. She succumbed to the illness later that fall. But unbeknownst to Lacks or her family, her doctors had taken tissue samples from her cervix during treatment. Soon enough, these samples ended up in the possession of George Otto Gey, a Johns Hopkins cancer researcher.
HeLa cells have become a crucial aspect of medical research and development to this day, helping scientists study everything from polio to the physiological effects of outer space. But it wasn’t until the 1970s that doctors even bothered to tell Lacks’sIt wasn’t customary at the time for researchers to seek permission for the use of tissue samples from patients. But the resulting controversy did help lead to the development of standardized informed consent practices by the 1980s.
family has argued that they are still entitled to some compensation from these companies. In 2021, the family sued Thermo Fisher Scientific, making the case that the company continued to unfairly profit from the commercializing of HeLa cells long after their origin was publicly disclosed.“The exploitation of Henrietta Lacks represents the unfortunately common struggle experienced by Black people throughout history,” the family’s original complaint read.
On Tuesday, following closed-door negotiations, both sides confirmed that they have now reached an amicable if confidential settlement.“The parties are pleased that they were able to find a way to resolve this matter outside of Court and will have no further comment about the settlement,” representatives for both Thermo Fisher and the Lacks family said in a joint statement, the AP
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Herkunft: FOX10Phoenix - 🏆 83. / 68 Weiterlesen »
Herkunft: HuffPostWomen - 🏆 27. / 68 Weiterlesen »